GlucoTrack director Paul V. Goode resigns citing potential conflict of interest
GlucoTrack director Paul V. Goode resigned from the board on Sept. 14, 2026, effective immediately. Goode cited a potential conflict of interest tied to talks over duties and obligations under the Lokahi Therapeutics merger agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generativ